"Treat to target" recommendations in ulcerative colitis in practice: clinician perceptions and potential barriers by Bryant, R, Costello, S, Schoeman, S, Sathananthan, D, Lau, S, Schoeman, M, Mountifield, R, Tee, D, Travis, S, Andrews, J

Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice by Bryant, R, Costello, S, Schoeman, S, Sathananthan, D, Knight, E, Lau, S, Schoeman, M, Mountifield, R, Tee, D, Travis, S, Andrews, J

IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies by Friedrich, M, Pohin, M, Jackson, MA, Korsunsky, I, Bullers, SJ, Rue-Albrecht, K, Christoforidou, Z, Sathananthan, D, Thomas, T, Ravindran, R, Tandon, R, Peres, RS, Sharpe, H, Wei, K, Watts, GFM, Mann, EH, Geremia, A, Attar, M, Barone, F, Brenner, M, Buckley, CD, Coles, M, Frei, AP, Lassen, KG, Powrie, FM, McCuaig, S, Thomas, L, Collantes, E, Uhlig, HH, Sansom, SN, Easton, A, Raychaudhuri, S, Travis, SP, Powrie, FM

A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease by Thomas, T, Friedrich, M, Rich-Griffin, C, Pohin, M, Agarwal, D, Pakpoor, J, Lee, C, Tandon, R, Rendek, A, Aschenbrenner, D, Jainarayanan, A, Voda, A, Siu, JHY, Sanches-Peres, R, Nee, E, Sathananthan, D, Kotliar, D, Todd, P, Kiourlappou, M, Gartner, L, Ilott, N, Issa, F, Hester, J, Turner, J, Mackerodt, J, Marsden, B, Taylor, S, Coles, M, Jostins-Dean, L, Powrie, FM, Travis, S, Uhlig, HH, Dendrou, CA, Buckley, CD